Oumédaly Reman

7.3k citations
67 papers · 3.0k indexed · h-index 28

Oumédaly Reman

67 papers receiving 2.9k citations

Peers

Oumédaly Reman
Comparison fields: 5 of 82
  • Hematology 1.9k
  • Genetics 619
  • Public Health, Environmental and Occupational Health 1.4k
  • Pathology and Forensic Medicine 610
  • Oncology 811
Replace Arend von Stackelberg with:
Arend von Stackelberg Germany
David S. Viswanatha United States
Thomas J. Nevill Canada
J T Sandlund United States
DJ Pullen United States
Asad Bashey United States
Luciana Annino Italy
Françoise Rigal‐Huguet France
Nick Bown United Kingdom
R. Kuse Germany
Oumédaly Reman relative to Arend von Stackelberg Germany Arend von Stackelberg's profile →
Citations per field
00.5×1.5×2.2×
Arend von Stackelberg · 1×
Citations per year

Countries citing papers authored by Oumédaly Reman

Since Specialization
Citations

This map shows the geographic impact of Oumédaly Reman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oumédaly Reman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oumédaly Reman more than expected).

Fields of papers citing papers by Oumédaly Reman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oumédaly Reman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oumédaly Reman. The network helps show where Oumédaly Reman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Oumédaly Reman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Oumédaly Reman Line = papers co-authored together Oumédaly Reman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20159
2 201335
3 201338
4 20131
5 201335
6 20121
7 20129
8 201126
9 200949
10 200838
11 200717
12 2007184
13 2006226
14 2006234
15 200528
16 200413
17 20048
18 200032
19 19998
20 199656

About Oumédaly Reman

Oumédaly Reman is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 67 papers that have together received 3.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (27 papers), Lymphoma Diagnosis and Treatment (17 papers), Hematopoietic Stem Cell Transplantation (16 papers), Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Neutropenia and Cancer Infections (7 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (619 citations) and Public Health, Environmental and Occupational Health (1.4k citations). Oumédaly Reman has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Xavier Thomas, Hervé Dombret, Agnès Buzyn, Véronique Lhéritier, Pascal Turlure, Claude Gardin, Emmanuel Raffoux, Pierre Fenaux, Cécile Pautas and Françoise Huguet. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026